158 related articles for article (PubMed ID: 24613814)
1. Arterial perfusion imaging-defined subvolume of intrahepatic cancer.
Wang H; Farjam R; Feng M; Hussain H; Ten Haken RK; Lawrence TS; Cao Y
Int J Radiat Oncol Biol Phys; 2014 May; 89(1):167-74. PubMed ID: 24613814
[TBL] [Abstract][Full Text] [Related]
2. Prediction of liver function by using magnetic resonance-based portal venous perfusion imaging.
Cao Y; Wang H; Johnson TD; Pan C; Hussain H; Balter JM; Normolle D; Ben-Josef E; Ten Haken RK; Lawrence TS; Feng M
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):258-63. PubMed ID: 22520476
[TBL] [Abstract][Full Text] [Related]
3. A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases.
Robertson JM; McGinn CJ; Walker S; Marx MV; Kessler ML; Ensminger WD; Lawrence TS
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1087-92. PubMed ID: 9392548
[TBL] [Abstract][Full Text] [Related]
4. An emerging role for radiation therapy in the treatment of hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Wo JY; Dawson LA; Zhu AX; Hong TS
Surg Oncol Clin N Am; 2014 Apr; 23(2):353-68. PubMed ID: 24560114
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced ultrasound (DCE-US) for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma.
Wildner D; Pfeifer L; Goertz RS; Bernatik T; Sturm J; Neurath MF; Strobel D
Ultraschall Med; 2014 Dec; 35(6):522-7. PubMed ID: 25202903
[TBL] [Abstract][Full Text] [Related]
6. Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage: A Phase 2 Clinical Trial.
Feng M; Suresh K; Schipper MJ; Bazzi L; Ben-Josef E; Matuszak MM; Parikh ND; Welling TH; Normolle D; Ten Haken RK; Lawrence TS
JAMA Oncol; 2018 Jan; 4(1):40-47. PubMed ID: 28796864
[TBL] [Abstract][Full Text] [Related]
7. Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?
Wang X; Wang W; Ma X; Lu X; Li S; Zeng M; Xu K; Yang C
Eur Radiol; 2020 Oct; 30(10):5337-5347. PubMed ID: 32385649
[TBL] [Abstract][Full Text] [Related]
8. Change in diffusion weighted MRI during liver cancer radiotherapy: preliminary observations.
Eccles CL; Haider EA; Haider MA; Fung S; Lockwood G; Dawson LA
Acta Oncol; 2009; 48(7):1034-43. PubMed ID: 19634060
[TBL] [Abstract][Full Text] [Related]
9. A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors.
Hong TS; DeLaney TF; Mamon HJ; Willett CG; Yeap BY; Niemierko A; Wolfgang JA; Lu HM; Adams J; Weyman EA; Arellano RS; Blaszkowsky LS; Allen JN; Tanabe KK; Ryan DP; Zhu AX
Pract Radiat Oncol; 2014; 4(5):316-322. PubMed ID: 25194100
[TBL] [Abstract][Full Text] [Related]
10. Radiation therapy for liver tumors: ready for inclusion in guidelines?
Tanguturi SK; Wo JY; Zhu AX; Dawson LA; Hong TS
Oncologist; 2014 Aug; 19(8):868-79. PubMed ID: 25001265
[TBL] [Abstract][Full Text] [Related]
11. Image-guided radiation therapy for liver tumors: gastrointestinal histology matters.
Katsoulakis E; Riaz N; Cannon DM; Goodman K; Spratt DE; Lovelock M; Yamada Y
Am J Clin Oncol; 2014 Dec; 37(6):561-7. PubMed ID: 23466584
[TBL] [Abstract][Full Text] [Related]
12. [Hepatocellular carcinoma and cholangiocarcinoma].
Rauchfuss F; Scheuerlein H; Götz M; Dittmar Y; Voigt R; Heise M; Settmacher U
Chirurg; 2010 Oct; 81(10):941-52; quiz 953. PubMed ID: 20827454
[TBL] [Abstract][Full Text] [Related]
13. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.
Hoffmann RT; Paprottka PM; Schön A; Bamberg F; Haug A; Dürr EM; Rauch B; Trumm CT; Jakobs TF; Helmberger TK; Reiser MF; Kolligs FT
Cardiovasc Intervent Radiol; 2012 Feb; 35(1):105-16. PubMed ID: 21431970
[TBL] [Abstract][Full Text] [Related]
14. An approach to identify, from DCE MRI, significant subvolumes of tumors related to outcomes in advanced head-and-neck cancer.
Wang P; Popovtzer A; Eisbruch A; Cao Y
Med Phys; 2012 Aug; 39(8):5277-85. PubMed ID: 22894453
[TBL] [Abstract][Full Text] [Related]
15. Regional chemotherapy for unresectable intrahepatic cholangiocarcinoma: a potential role for dynamic magnetic resonance imaging as an imaging biomarker and a survival update from two prospective clinical trials.
Konstantinidis IT; Do RK; Gultekin DH; Gönen M; Schwartz LH; Fong Y; Allen PJ; D'Angelica MI; DeMatteo RP; Klimstra DS; Kemeny NE; Jarnagin WR
Ann Surg Oncol; 2014 Aug; 21(8):2675-83. PubMed ID: 24664624
[TBL] [Abstract][Full Text] [Related]
16. Impact of intravenous contrast enhancement phase on target definition for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (IHC): Observations from patients enrolled on a prospective phase 2 trial.
Niska JR; Keane FK; Wolfgang JA; Hahn PF; Wo JY; Zhu AX; Hong TS
Pract Radiat Oncol; 2016; 6(1):e9-16. PubMed ID: 26598907
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of hepatic artery fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers.
Robertson JM; Lawrence TS; Andrews JC; Walker S; Kessler ML; Ensminger WD
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):325-30. PubMed ID: 9069303
[TBL] [Abstract][Full Text] [Related]
18. Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Hong TS; Wo JY; Yeap BY; Ben-Josef E; McDonnell EI; Blaszkowsky LS; Kwak EL; Allen JN; Clark JW; Goyal L; Murphy JE; Javle MM; Wolfgang JA; Drapek LC; Arellano RS; Mamon HJ; Mullen JT; Yoon SS; Tanabe KK; Ferrone CR; Ryan DP; DeLaney TF; Crane CH; Zhu AX
J Clin Oncol; 2016 Feb; 34(5):460-8. PubMed ID: 26668346
[TBL] [Abstract][Full Text] [Related]
19. DCE-MRI defined subvolumes of a brain metastatic lesion by principle component analysis and fuzzy-c-means clustering for response assessment of radiation therapy.
Farjam R; Tsien CI; Lawrence TS; Cao Y
Med Phys; 2014 Jan; 41(1):011708. PubMed ID: 24387500
[TBL] [Abstract][Full Text] [Related]
20. Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization.
Camacho JC; Kokabi N; Xing M; Prajapati HJ; El-Rayes B; Kim HS
J Vasc Interv Radiol; 2014 Feb; 25(2):256-65. PubMed ID: 24461131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
